《大行報告》高盛下調人保(01339.HK)目標價至3.6元 評級「買入」
高盛發表報告,上調人保(01339.HK)今年盈利預測11%,反映來自財險(02328.HK)的承保利潤上升,及壽險與健康險於第三季的盈利表現優於預期。
不過,由於資金成本上升及長期投資回報的不明朗,高盛稱人保人壽於第三季明顯減少其單次保單銷售,預期此審慎策略將導致明年及2024年的盈利增長放慢,因此該行將業務此兩年的盈利預測下調分別11%及16%,集團整體盈利預測亦調低3%及4%。
高盛同時下調人保H股目標價,由3.7元降至3.6元,評級維持「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.